<DOC>
	<DOCNO>NCT02210494</DOCNO>
	<brief_summary>Evaluate safety Secretrol® patient undergo endoscopic mucosal resection early adenocarcinoma esophagus .</brief_summary>
	<brief_title>Safety Secretrol® Short-term Management Patients Undergoing Endoscopic Mucosal Resection ( EMR )</brief_title>
	<detailed_description />
	<criteria>Category 4highgrade intraepithelial neoplasia Ages 18 older sign Informed Consent Form sign Health Insurance Portability Accountability Act ( HIPAA ) Authorization Form Clinically relevant data suggest unknown disease require evaluation Primary Investigator . Patients renal failure organ transplant . Patients know allergic reaction Proton Pump Inhibitors ( PPI ) . Participation another study would interfere study endpoint within 30 day prior screen . Previous enrollment current study . Patient Investigator , family member employee investigational site . Patient know suspect involved alcohol drug abuse . Known suspected history noncompliance medication . Inability follow procedure study ( e.g. , due language problem , psychological disorder ) Patients receive prohibit concomitant medication include PPIs , H2blockers , sucralfate , misoprostol . Patients receive prohibit concomitant medication include clopidogrel , ketoconazole , digoxin , diazepam , warfarin , phenytoin , emtricitabine/nelfinavir/tenofovir , atazanavir , citalopram , emtricitabine/rilpivirine/tenofovir , rilpivirine , nelfinavir , tricyclic antidepressant , baclofen , tacrolimus , cyclosporine , cilostazol , disulfiram , methotrexate , voriconazole . Pregnancy intention become pregnant course study , breast feeding , unwillingness use highly effective mean contraception ( oral contraception intrauterine device ) . Prescription Nonsteroidal antiinflammatory Drug ( NSAID ) aspirin use : The patient must able stop med 1 week prior screen treatment . History upper gastrointestinal surgery , ZollingerEllison syndrome , esophageal stricture , peptic stricture , duodenal ⁄ gastric ulcer , esophageal motility disorder , Inflammatory Bowel Disease ( IBD ) , AIDS , pancreatitis , malabsorption , severe cardiovascular pulmonary disease , liver disease , active malignant disease , Scleroderma , diabetes mellitus , autonomic peripheral neuropathy , myopathy , functional bowel disorder underlie disease medication might affect low esophageal sphincter pressure increase acid clearance time . Subject unable unwilling fully complete stage study . Unable sign inform consent inability give fully inform consent due language problem , psychological disorder mental deficiency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>